Education
About Us
Working with TipRanks
Follow Us
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 283.06M | $ 235.13M | $ 175.51M | $ 134.03M | $ 45.60M |
| Gross Profit | $ 250.39M | $ 206.88M | $ 161.37M | $ 128.37M | $ 44.51M |
| Operating Income | $ 104.91M | $ -4.69M | $ -91.69M | $ -111.47M | $ -180.74M |
| EBITDA | $ 127.76M | $ 31.73M | $ -63.05M | $ -103.65M | $ -177.44M |
| Net Income | $ 287.20M | $ 5.75M | $ -78.02M | $ -108.18M | $ -180.97M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 398.00M | $ 358.48M | $ 350.49M | $ 389.39M | $ 466.08M |
| Total Assets | $ 751.59M | $ 550.64M | $ 548.06M | $ 470.86M | $ 543.37M |
| Total Debt | $ 74.81M | $ 79.37M | $ 97.61M | $ 8.09M | $ 8.74M |
| Net Debt | $ -5.40M | $ -4.06M | $ 48.73M | $ -86.08M | $ -223.16M |
| Total Liabilities | $ 170.26M | $ 173.17M | $ 170.11M | $ 65.42M | $ 64.28M |
| Stockholders' Equity | $ 581.33M | $ 377.48M | $ 377.95M | $ 405.44M | $ 479.09M |
| Cash Flow | |||||
| Free Cash Flow | $ 135.41M | $ 44.11M | $ -34.18M | $ -79.82M | $ -159.19M |
| Operating Cash Flow | $ 135.66M | $ 44.39M | $ -33.46M | $ -79.53M | $ -157.69M |
| Investing Cash Flow | $ -32.77M | $ 39.26M | $ -6.71M | $ -60.63M | $ -103.87M |
| Financing Cash Flow | $ -106.11M | $ -49.09M | $ -5.13M | $ 2.43M | $ 221.11M |